<?xml version="1.0" encoding="UTF-8"?><?xml-model type="application/xml-dtd" href="http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" dtd-version="1.1d3" specific-use="Marcalyc 1.2" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="redalyc">2738</journal-id>
<journal-title-group>
<journal-title specific-use="original" xml:lang="es">Archivos de Medicina (Col)</journal-title>
<abbrev-journal-title abbrev-type="publisher" xml:lang="es">Arch Med</abbrev-journal-title>
</journal-title-group>
<issn pub-type="ppub">1657-320X</issn>
<issn pub-type="epub">2339-3874</issn>
<publisher>
<publisher-name>Universidad de Manizales</publisher-name>
<publisher-loc>
<country>Colombia</country>
<email>cim@umanizales.edu.co</email>
</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="art-access-id" specific-use="redalyc">273860963012</article-id>
<article-id pub-id-type="doi">https://doi.org/10.30554/archmed.19.2.3298.2019</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Artículos de Investigación</subject>
</subj-group>
</article-categories>
<title-group>
<article-title xml:lang="en">
<bold>Maternal risk factors in full-term newborns with early onset sepsis related with Interleukin-6 in umbilical blood</bold>
</article-title>
<trans-title-group>
<trans-title xml:lang="es">Factores de riesgo maternos en recién nacidos a término con sepsis de aparición temprana relacionada con interleucina-6 en sangre umbilical</trans-title>
</trans-title-group>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="no">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2091-9095</contrib-id>
<name name-style="western">
<surname>González-Andrade</surname>
<given-names>Fabricio</given-names>
</name>
<xref ref-type="aff" rid="aff1"/>
<email>fabriciogonzaleza@gmail.com.</email>
</contrib>
<contrib contrib-type="author" corresp="no">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-4878-4700</contrib-id>
<name name-style="western">
<surname>Castillo Rojas</surname>
<given-names>Andrea</given-names>
</name>
<xref ref-type="aff" rid="aff2"/>
<email>enana_agcr@hotmail.com</email>
</contrib>
<contrib contrib-type="author" corresp="no">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6274-2195</contrib-id>
<name name-style="western">
<surname>Aguinaga Romero</surname>
<given-names>Gabriela</given-names>
</name>
<xref ref-type="aff" rid="aff3"/>
<email>gabrielaaguinaga@yahoo.com</email>
</contrib>
</contrib-group>
<aff id="aff1">
<institution content-type="original">MD, PhD. Translational Medicine Unit, Faculty of Medical Sciences at Central University of Ecuador. Quito, Ecuador. ORCID: 0000-0002-2091-9095</institution>
<institution content-type="orgname">Faculty of Medical Sciences at Central University of Ecuador</institution>
<country country="EC">Ecuador</country>
</aff>
<aff id="aff2">
<institution content-type="original">MD. Translational Medicine Unit, Faculty of Medical Sciences at Central University of Ecuador. Quito, Ecuador. ORCID: 0000-0002-4878-4700</institution>
<institution content-type="orgname"> Faculty of Medical Sciences at Central University of Ecuador</institution>
<country country="EC">Ecuador</country>
</aff>
<aff id="aff3">
<institution content-type="original">MD. Translational Medicine Unit, Faculty of Medical Sciences at Central University of Ecuador. Quito, Ecuador. ORCID: 0000-0002-6274-2195</institution>
<institution content-type="orgname">Faculty of Medical Sciences at Central University of Ecuador</institution>
<country country="EC">Ecuador</country>
</aff>
<pub-date pub-type="epub-ppub">
<season>July-December</season>
<year>2019</year>
</pub-date>
<volume>19</volume>
<issue>2</issue>
<fpage>320</fpage>
<lpage>330</lpage>
<history>
<date date-type="received" publication-format="dd mes yyyy">
<day>07</day>
<month>04</month>
<year>2019</year>
</date>
<date date-type="corrected" publication-format="dd mes yyyy">
<day>18</day>
<month>07</month>
<year>2019</year>
</date>
<date date-type="accepted" publication-format="dd mes yyyy">
<day>24</day>
<month>07</month>
<year>2019</year>
</date>
</history>
<permissions>
<ali:free_to_read/>
</permissions>
<self-uri content-type="html" xlink:href="http://revistasum.umanizales.edu.co/ojs/index.php/archivosmedicina/article/view/3298">http://revistasum.umanizales.edu.co/ojs/index.php/archivosmedicina/article/view/3298</self-uri>
<abstract xml:lang="en">
<title>Abstract</title>
<p>
<bold>Objective:</bold> to determine the relationship and association of early sepsis with interleukin-6 measured in umbilical blood, as well as gestational age and birth weight, prenatal history of the mother pathologies during pregnancy, in newborns at the Neonatology Service of Carlos Andrade Marín Hospital (Quito). <bold>Material and methods:</bold> epidemiological, observational, analytical, cross-sectional. 200 newborns were analyzed. IL-6 was determined by Elisa. <bold>Results:</bold> newborn mean gestational age 38.4±2 weeks, mean weight 2871±532.4 grams, cutoff point interleukin 6 ≤14pg/uL; male sex was 43.9%, female sex 56.1%; preeclampsia of the mother 22.4%, infection of the urinary tract during pregnancy 20.4%; vaginitis/vaginosis 19.4%; IL6 values ≤ 14 pg/uL in 63.3% of patients; IL6 values of &gt;14 pg/uL 36.7%; relationship with sepsis in all, p&lt;0.05; relationship of prenatal pre-maternity of the mother and neonatal sepsis, p&lt;0.05; relationship between vaginitis/vaginosis of the mother with neonatal sepsis; p&lt;0.05; OR: 38.88 IC95% (4.912-307.728); association between sepsis and risk factors, IL6, gestational age in weeks, weight, prenatal preeclampsia and urinary tract infection, vaginitis/vaginosis, p&lt;0.05. <bold>Conclusion:</bold> it is concluded that there is a correlation of risk factors, such as gestational age in weeks, weight, prenatal preeclampsia, UTI prior to birth, vaginitis/vaginosis, and values of interleukin 6 ≤ 14 pg/uL. The mean gestational age was 38.4 weeks, and average weight 2871 grams in the newborns analyzed.</p>
</abstract>
<trans-abstract xml:lang="es">
<title>Resumen</title>
<p>
<bold> Objetivo:</bold> determinar la relación de sepsis temprana con interleucina 6 medida en sangre umbilical, así como la edad gestacional y el peso al nacer, antecedentes prenatales de patologías maternas durante el embarazo, en recién nacidos en el Servicio de Neonatología del Hospital Carlos Andrade Marín (Quito). <bold>Materiales y métodos: </bold>estudio epidemiológico, observacional, analítico, transversal. Se analizaron 200 recién nacidos. La IL-6 fue determinada por Elisa. <bold>Resultados:</bold> edad gestacional promedio del recién nacido 38.4±2 semanas, peso promedio 2871±532.4 gramos, punto de corte interleucina 6 ≤14pg/uL; el sexo masculino fue del 43,9%, el sexo femenino del 56,1%; preeclampsia de la madre 22.4%, infección del tracto urinario durante el embarazo 20.4%; vaginitis/vaginosis 19,4%; Valores promedio de IL6 ≤14 pg/uL en el 63,3% de los pacientes; valores de IL6 de&gt; 14 pg/uL en 36.7% de pacientes; relación con sepsis en total, p&lt;0.05; relación de la pre-maternidad prenatal de la madre y sepsis neonatal con p &lt;0.05; relación entre vaginitis/vaginosis de la madre con sepsis neonatal con p&lt;0.05; OR (verosimilitud): 38,88 IC95% (4.912-307.728); asociación entre sepsis y factores de riesgo, IL6, edad gestacional en semanas, peso, preeclampsia prenatal e infección del tracto urinario, vaginitis/vaginosis, p &lt;0,05. <bold>Conclusión</bold>: se concluye que existe correlación de factores de riesgo como la edad gestacional en semanas, el peso, la preeclampsia prenatal, la infección de vías urinarias antes del nacimiento, la vaginitis/vaginosis y los valores de interleucina 6 ≤1 4 pg/uL. La edad gestacional media fue de 38,4 semanas y el peso promedio de 2871 gramos en los recién nacidos analizados.</p>
</trans-abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>risk factors</kwd>
<kwd> biomarkers</kwd>
<kwd> interleukin-6</kwd>
<kwd> pre-eclampsia</kwd>
<kwd> newborn</kwd>
<kwd> neonatal sepsis</kwd>
</kwd-group>
<kwd-group xml:lang="es">
<title>Palabras clave</title>
<kwd>factores de riesgo</kwd>
<kwd> biomarcadores</kwd>
<kwd> interleucina-6</kwd>
<kwd> pre-eclampsia</kwd>
<kwd> recién nacido</kwd>
<kwd> sepsis neonatal</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="28"/>
</counts>
</article-meta>
</front>
<body>
<sec sec-type="intro">
<title>
<bold>Introduction</bold>
</title>
<p>Neonatal sepsis is a systemic infection occurring in infants at ≤28 days of life, and it is an important cause of newborn morbidity and mortality. The signs and symptoms are nonspecific and make diagnosis difficult; routine tests are not completely effective, are nonspecific, and cause the inappropriate use of antibiotics [<xref ref-type="bibr" rid="redalyc_273860963012_ref1">1</xref>]. Sepsis is the result of an infection associated with a systemic inflammatory response and with production and release of a wide range of inflammatory mediators. It is necessary to analyze cytokines [<xref ref-type="bibr" rid="redalyc_273860963012_ref2">2</xref>] which are potent inflammatory mediators. Serum levels also increase during infections, therefore changes can occur from other inflammatory effector molecules.  Group B streptococcus (GBS) is the most common etiologic agent, while Escherichia coli is the most common cause of mortality [<xref ref-type="bibr" rid="redalyc_273860963012_ref4">3</xref>].</p>
<p>			The diagnosis of neonatal sepsis is based on a combination of clinical presentation; the use of nonspecific markers, including C-reactive protein (CRP) and procalcitonin (PCT), and blood cultures [<xref ref-type="bibr" rid="redalyc_273860963012_ref5">4</xref>]. Cytokines, including interleukin 6 (IL-6), interleukin 8 (IL-8), gamma interferon (IFN-γ), and tumor necrosis factor alpha (TNF-α), and cell surface antigens, including soluble intercellular adhesion molecule (sICAM) and CD64, are also used as nonspecific screening measures for neonatal sepsis [<xref ref-type="bibr" rid="redalyc_273860963012_ref6">5</xref>,<xref ref-type="bibr" rid="redalyc_273860963012_ref7">6</xref>]. </p>
<p>			Neonatal sepsis is a clinical situation that requires rapid action and the establishment of adequate antimicrobial therapy. The initial symptoms are usually nonspecific; respiratory manifestations are the first to appear. Neonatal sepsis has an incidence of 1-10 cases per 1,000 live births and a high mortality rate. IL-6 has a sensitivity of 87-100%, a negative predictive value between 93 and 100% [61]. It is effective for the diagnosis of late neonatal sepsis in preterm infants. At the beginning of the infection it has a high sensitivity (89%) and a negative predictive value of 91% [<xref ref-type="bibr" rid="redalyc_273860963012_ref8">7</xref>].</p>
<p>			Cytokines are proteins secreted by the cells of innate and adaptive immunity that mediate cellular functions. Cytokines have pleiotropic and redundant action, and are secreted freely and self-limited. They influence the synthesis and actions of other cytokines, may have local and/or systemic action, and initiate their actions by joining specific membrane receptors in the target cells. Cytokines are regulated by external signals, and cause changes in the gene expression of target cells and have inhibitory mechanisms of feed-back [<xref ref-type="bibr" rid="redalyc_273860963012_ref9">8</xref>]. </p>
<p>			Interleukin 6 (IL-6) is a cytokine that is synthesized by mononuclear phagocytes, vascular endothelial cells, fibroblasts, and other cytokines such as IL1 and TNF. The functional form and IL6 is a homodimer, and each subunit forms a globular domain with four alpha helices. The IL6 receptor is formed by a cytokine binding protein and a subunit for signal transduction, and both belong to the cytokine receptor family of type I [<xref ref-type="bibr" rid="redalyc_273860963012_ref10">9</xref>]. IL-6 has several actions. In innate immunity, it stimulates the synthesis of proteins of the acute phase by hepatocytes, and also stimulates the production of neutrophils from progenitors of the bone marrow in synergy with colony stimulating factors. In adaptive immunity, it stimulates the growth of lymphocytes B, producers of antibodies, lymphocytes T, and induces fever. In addition, IL-6 acts as an autocrine growth factor in neoplasic cells. It also stimulates the synthesis of other proinflammatory cytokines, especially IL-17 [<xref ref-type="bibr" rid="redalyc_273860963012_ref11">10</xref>].</p>
<p>			According to some studies, IL-6 could play a key role in the inflammatory response to microbial pathogens. In the same way, a high IL-6 level was associated with increased severe sepsis mortality and risk, and IL-6 has also been investigated among other infection markers to improve the diagnostics of suspected neonatal infection. Furthermore, IL-6 signal pathway was essential to systemic inflammation in mice studies. For this reason, it could be possible to be related to a gene for sepsis [<xref ref-type="bibr" rid="redalyc_273860963012_ref12">11</xref>]. A systemic fetal cytokine response, defined as a plasma interleukin-6 (IL-6) value above 11 pg/m is considered a major independent risk factor, such as fetal inflammatory response syndrome (FIRS), a diagnostic marker of early-onset neonatal sepsis (EONS) and a risk predictor of white matter injury (WMI) [<xref ref-type="bibr" rid="redalyc_273860963012_ref13">12</xref>]. </p>
<p>			Persistently elevated levels of IL-6 in plasma below peak values are considered predictors of poor prognosis in patients with septic shock [<xref ref-type="bibr" rid="redalyc_273860963012_ref14">13</xref>]. Increased levels of plasma IL-6 in patients with sepsis correlate with the severity of septic shock, and an increase in serum levels of IL-6 during sepsis is associated with an increased incidence of shock and worse prognosis. IL-6 seems to be a better parameter to assess the severity of sepsis, occurring as early as two to four hours after the onset of the inflammatory response [<xref ref-type="bibr" rid="redalyc_273860963012_ref15">14</xref>]. </p>
<p>			The aim of this research is to determine the relationship and association of early sepsis with interleukin-6, measured in umbilical blood, as well as gestational age and birth weight, and prenatal history of the mother in full-term newborns with and without risk factors.</p>
</sec>
<sec sec-type="materials|methods">
<title>
<bold>Material and methods</bold>
</title>
<p>
<bold>Research design.</bold> Epidemiological, observational, analytical, cross-sectional design.</p>
<p>
<bold>			Sampling:</bold> it analyzed two cohorts of patients, born at the Neonatology Service of the Carlos Andrade Marín Hospital (HCAM), located in the Metropolitan District of Quito, Ecuador; through 2016 and 2017. Samples correspond to full-term newborns with risk factors for early sepsis (n=100), and full-term newborns without risk factors (n=100). It used finite universe sampling calculations, however, the number of patients obtained was less than 100, for that reason, it selected randomly two cohorts of 100 patients to reach a discrimination power of 80%.</p>
<p>
<bold>			Inclusion criteria: </bold>patients with risk factors, patients whose mothers have had urinary tract infections (UTIs) without treatment, or other related infections. Exclusion criteria: patients older than 37 weeks without risk factors, patients whose mothers have not presented any infection, or received treatment. Criteria for elimination: patients who have died post-partum by any clinical condition.</p>
<p>			Specific methods: an information collection sheet was used to gather all information required. IL-6 was determined by conventional electrochemiluminescence immunoassay (ECLIA) method, at the Central Laboratory in the hospital. </p>
<p>
<bold>			Ethical criteria:</bold> approval was obtained from the Ethics Committee in Human Research of the hospital, and by the Institutional Review Board (IRB) of the Central University of Ecuador. Information was collected from a secondary source (medical records), therefore, no informed consent was required. In terms of confidentiality, the protection of the identity of the persons participating in the investigation was ensured, the study has no potential risks, and it provides benefits in future applications.</p>
<p>
<bold>			Data analysis:</bold> data collection, analysis and evaluation were collected in an Excel database to be analyzed with the IBM SPSS© software version 22, licensed. It used descriptive statistics, measures of central tendency, and measures of variability (spread). Measures of central tendency include the mean, median, and mode, while measures of variability include the standard deviation, variance, the minimum and maximum variables, and the kurtosis and skewness. The relationship model of the observed variables with neonatal sepsis was analyzed using binary logistic regression.</p>
</sec>
<sec sec-type="results">
<title>
<bold>Results</bold>
</title>
<p>Distribution of newborn sex, risk factors, sepsis and IL-6. 200 children were analized, including males (43.9%) and females (56.1%). In relation to the mother’s medical history that constitutes risk factors for sepsis for the child, 22 showed prenatal preeclampsia (22.4%), and 20 showed UTI (20.4%). Likewise, prenatal vagintis and vaginosis were found in 19 mothers (19.4%). 43 children (43.9%) developed sepsis. In relation to IL-6, 62 children had ≤ 14pg/uL (63.3%) while 36 children showed IL-6 &gt;14 pg/uL (36.7%). In the relationship with sepsis, statistical significance was found p&lt;0.05 with all the variables, except with newborn sex. p&gt;0.05. See <xref ref-type="fig" rid="gf1">Table 1</xref>.</p>
<p>
<fig id="gf1">
<label>
<bold>Table 1.</bold>
</label>
<caption>
<title>
<bold>Distribution of newborn sex, risk factors, sepsis and interleukin-6</bold>
</title>
</caption>
<alt-text>Table 1.  Distribution of newborn sex, risk factors, sepsis and interleukin-6</alt-text>
<graphic xlink:href="273860963012_gf2.png" position="anchor" orientation="portrait"/>
<attrib>Neonatology Service. Hospital Carlos Andrade Marín (Quito, Ecuador)</attrib>
</fig>
</p>
<p>Distribution of the most important findings related to weight, gestational age in weeks, and IL6. An average weight of 2870.7±532.4 grams was found in the neonates. The minimum weight was 1015 g and the maximum of 4180 g. The P25 was 2611.3 g. and the P50 of 2950 g. The P63 is 3106.7 g and corresponds to the cutoff point for IL-6, of ≤ 14 pg/ul, P75 is 3207.5 g. The average gestational age is 38.4±2 weeks; the lowest value was 31 weeks and the maximum was 40 weeks, with a range of 19 weeks, the P25 is 37.2 weeks. P50 38.6 weeks. P63 corresponds to 39.2 weeks, and is related to the cut of interleukin 6, of ≤14 pg/ul. P75 is 39.7 weeks; the mean of interleukin 6 is 58±99.1 pg/ul, the minimum value is 0 and the maximum value is 414 pg/ul, the P25 is 0.1 pg/ul, the P50 is 0.4 pg/ul. P75 is 101.5 pg/ul. See <xref ref-type="fig" rid="gf2">Table 2</xref>.</p>
<p>
<fig id="gf2">
<label>
<bold>Table 2</bold>
</label>
<caption>
<title>
<bold>Distribution of the most important findings related to weight, gestational age in weeks and interleukin-6.</bold>
</title>
<p>Me=average; EE=standard error; Md=median; S=standard deviation; S2=variance.</p>
</caption>
<alt-text>Table 2 Distribution of the most important findings related to weight, gestational age in weeks and interleukin-6.</alt-text>
<graphic xlink:href="273860963012_gf3.png" position="anchor" orientation="portrait"/>
<attrib>Neonatology Service. Hospital Carlos Andrade Marín (Quito, Ecuador)</attrib>
</fig>
</p>
<p>Distribution of the relationship between sepsis with prenatal preeclampsia, vaginitis, prenatal vaginosis, and newborn sex. In the study of prenatal infections and neonatal sepsis, it can be seen that of 43 cases of sepsis, 17 mothers of neonates who developed sepsis (39.5%) presented prenatal preeclampsia, and 26 (60.5%), despite newborn sepsis, did not present preeclampsia before birth. Of the 55 neonates who did not have sepsis, five of their mothers (9.1%) had prenatal preeclampsia and 50 mothers of neonates (90.9%) did not present preeclampsia.</p>
<p>			The relationship between vaginitis or prenatal vaginosis of the mother with neonatal sepsis. Of 43 children with sepsis, 18 patients’ mothers had vaginitis or prenatal vaginosis (41.9%) and 25 patients presented sepsis (58.1%). 55 neonates did not present sepsis, despite the fact that one mother had a history of vaginitis or vaginosis (1.8%), and 54 neonates did not have sepsis (98.2%) and neither did the mother have a history of vaginitis or prenatal vaginosis; statistical significance was found (p=0.000). When a mother has vaginitis or vaginosis there is 39 times more risk of developing neonatal sepsis. OR: 38.88 IC95% (4.912-307.788). Concerning the link between sex and sepsis, of 43 patients with sepsis, 23 children (53.5%) corresponded to male sex and 20 to female sex (46.5%); 55 children did not develop sepsis including 20 boys (36.4%) and 35 girls (63.6%). No statistical significance was found p&gt;0.05 (p=0.090). In the case of the relationship between UTI with sepsis, it was not possible to establish the contingency table, because a quadrant generated zero (0). However, it observed that of 43 children with sepsis, 20 mothers had a UTI (46.5%), and 23 children had no previous history of this pathology in their mothers (53.5%). In the case of IL-6 (dichotomized) and sepsis, a zero was also presented in one of the quadrants, but in the same way it was observed that of 43 children with sepsis, seven had interleukin ≤ 14 pg/ul (13.3%) and 36 children presented interleukin &gt;14 pg/ul; while 55 children with interleukin ≤ 14 pg/ul did not have sepsis. See <xref ref-type="fig" rid="gf3">table 3</xref>.</p>
<p>
<fig id="gf3">
<label>
<bold>Table 3</bold>
</label>
<caption>
<title>
<bold>Distribution of the relationship between sepsis with prenatal preeclampsia vaginitis, vaginosis and newborn sex</bold>
</title>
</caption>
<alt-text>Table 3 Distribution of the relationship between sepsis with prenatal preeclampsia vaginitis, vaginosis and newborn sex</alt-text>
<graphic xlink:href="273860963012_gf4.png" position="anchor" orientation="portrait"/>
<attrib>Neonatology Service. Hospital Carlos Andrade Marín (Quito)</attrib>
</fig>
</p>
<p>Relationship model of the variables with neonatal sepsis. Using binary logistic regression, statistical significance was found (p &lt;0.05) in the connection between sepsis (endogenous variable) and the following exogenous variables (risk factors): IL-6 (p=0.0000), gestational age (weeks) (p=0.0030), weight (p=0.0000), prenatal preeclampsia (p=0.0000), prenatal UTI (p=0.0000), vaginitis/vaginosis (p=0.0000) and with sex. No statistical significance was found (p&gt;0.05). Therefore, it is concluded that there is a relationship between sepsis and the exogenous variables, considered a risk factor for sepsis in neonates with statistical significance of p&lt;0.05. See<xref ref-type="fig" rid="gf4"> table 4</xref>.</p>
<p>
<fig id="gf4">
<label>Table 4</label>
<caption>
<title>
<bold>Relationship model of the variables with neonatal sepsis using binary logistic regression</bold>
</title>
</caption>
<alt-text>Table 4 Relationship model of the variables with neonatal sepsis using binary logistic regression</alt-text>
<graphic xlink:href="273860963012_gf6.png" position="anchor" orientation="portrait"/>
<attrib>Neonatology Service. Hospital Carlos Andrade Marín (Quito)</attrib>
</fig>
</p>
</sec>
<sec sec-type="discussion">
<title>
<bold>Discussion</bold>
</title>
<p>
<bold>Distribution of newborn sex, risk factors, sepsis, and interleukin 6</bold>.</p>
<p>			A significant difference was found between sepsis and risk factors, such as pre-eclampsia in the prenatal period, infection of the urinary tract of the mother (UTI), vaginitis and/or prenatal vaginosis present in the mothers, and the quantification of IL-6 in umbilical cord blood less than 14 pg/uL. In addition, in this study there was a predominance of female sex, which contrasts with other studies where the predominance is male. This prevalence can be attributed to hormonal and genetic factors, and biological inflammatory markers related to the female sex, where they play a protective role. Another important factor is preeclampsia, which is attributed to oxidative stress and antioxidant status in neonates born to pre-eclamptic mothers. Another is sepsis due to infections of the urinary tract of the mother, in particular, bacteria that can invade and spread in the urinary system through the ascending lymphatic and hematogenous routes. All these factors contribute to low birth weight and/or a premature newborn, with strong evidence of intrauterine growth retardation.</p>
<p>			On the other hand, sepsis, secondary to prenatal vaginosis, is attributed to vertical transmission, caused by germs located in the maternal genital canal that contaminate the fetus ascending up the birth canal to reach the amniotic fluid or by direct contact of the fetus with contaminated secretions also passing through the birth canal. It is well known that sepsis contributes to morbidity and mortality in the neonatal period, so that diagnosis and early treatment improve its prognosis and outcome. The usefulness of IL-6 in the diagnosis of neonatal, early, and late sepsis is based on the concentrations of different cytokines in cord blood and in peripheral blood. Therefore, it is attributed to cytokines that act non-enzymatically as intercellular signals that modulate cellular function in the inflammatory response, regulating the growth, motility, and differentiation of leukocytes and non-leukocyte cells. Its functions are performed by the autocrine effect, that is, on the cell that produces it; the paracrine effect on the microenvironment of the cell, or the endocrine effect with distal action. In summary, the most important factors that explain the in vivo effects of IL-6 are the magnitude of its production, its half-life, body distribution, and the presence of natural inhibitors. </p>
<p>			In addition, several authors [<xref ref-type="bibr" rid="redalyc_273860963012_ref15">14</xref>,<xref ref-type="bibr" rid="redalyc_273860963012_ref16">15</xref>] report that septicemia is one of the main causes of mortality and morbidity in newborns, and establish that the increase in the level of IL-6 can occur before the C reactive protein (CPR) and can be used as a good index in the diagnosis of early sepsis compared to PC; therefore at the level of IL-6 is attributed its best determination of early sepsis compared to CPR6. Other study [<xref ref-type="bibr" rid="redalyc_273860963012_ref17">16</xref>] says that the reference value of IL-8 was &lt;14.1 pg/mL for healthy term infants administered vaginally and by cesarean section; for IL-6 the reference value is &lt;10.2 pg/mL. Early-onset sepsis remains a common and serious problem for neonates, especially premature infants. In another study, on the clinical validity of IL-6 determinations in preterm infants, the authors conclude that the concentration values measured in real days can be considered an early marker of sepsis. Similarly [<xref ref-type="bibr" rid="redalyc_273860963012_ref18">17</xref>], after studying the epidemiological characteristics of perinatal risk factors and neonatal outcomes, maternal age, pathologies of pregnancy and childbirth, as well as neonatal outcomes explain the risks of pathological conditions and the results of newborns are also related to the increase in IL-6 values. </p>
<p>			One author [<xref ref-type="bibr" rid="redalyc_273860963012_ref19">18</xref>] evaluated the diagnostic tests of inflammatory markers in maternal serum or umbilical cord blood for the diagnosis of onset of early neonatal sepsis in relation to diagnostic yield of procalcitonin (PCT), C-reactive protein (CRP), IL-6, and counting of leukocytes in umbilical cord blood or maternal serum for the diagnosis of early neonatal sepsis, obtaining similar conclusions. When they [<xref ref-type="bibr" rid="redalyc_273860963012_ref20">19</xref>] studied groups of infection by Gram-negative, Gram-positive, and by fungi, they described the optimal cut-off levels of IL-6 between the groups of Gram-negative and Gram-positive infections were 202 and 57 pg/mL respectively. The fungal infection group had higher CPR levels than the infection groups with Gram bacteria, and concluded that Gram-negative organisms resulted in 10-fold higher IL-6 production than the other groups of bacteria. </p>
<p>			The predictive value of PCT in umbilical cord blood and IL-6 in the diagnosis of early sepsis in premature infants has also been studied, and a negative correlation was found in the diagnosis of early sepsis with the presence of negative or positive clinical culture. The combination of PCT and IL-6 showed a sensitivity of 77% and specificity of 91.7%, which demonstrates its usefulness in the prediction of early sepsis. It also evaluated IL-6, IL-8, and IL-10 as possible markers of early diagnosis of neonatal infection and its relationship with the mortality and prognosis rate, and observed statistically significant differences between the control and case groups for the level of the three interleukins studied. They suggested a cut-off value of 10.85 pg/mL of IL-6, to discriminate between cases and controls, and a value of 78.2 pg/mL to predict mortality, and for IL-8 a cut-off value of 60 μg/mL was the value to differentiate definite versus indefinite infection. They attribute a greater potential to predict infection and possible mortality to IL-6, while IL-8 was valuable for the diagnosis of definitive infection.</p>
<p>			On the other hand, concentrations of IL-6 have also been determined [<xref ref-type="bibr" rid="redalyc_273860963012_ref21">20</xref>] during the microbial invasion of the amniotic cavity (MIAC) and amniotic fluid after delivery, and they evaluated the presence of acute histological chorioamnionitis (ACH) in the placenta. They also observed a greater intra-amniotic inflammatory response, which was mediated by IL-6 concentrations. It concluded that both MIAC and ACH affect the intensity of the intraamniotic inflammatory response and the incidence of early sepsis following subsequent delivery, to premature rupture of membranes before preterm labor between 34 and 37 weeks of pregnancy. They report that the fetal inflammatory response syndrome (FIRS) was defined with an IL-6 in umbilical cord blood greater than 11 pg/mL. The main parameter evaluated was a neonatal adverse result defined as in-hospital mortality and/or the presence of any of five pre-specified comorbidities, such as bronchopulmonary dysplasia, periventricular leukomalacia, intraventricular hemorrhage and early onset or onset of late sepsis [<xref ref-type="bibr" rid="redalyc_273860963012_ref22">21</xref>]. All of them presented FIRS with mean values of IL-6 of 51.8 pg/mL.</p>
<p>
<bold>			Distribution of the findings related to weight, gestational age in weeks and interleukin 6</bold>
</p>
<p>			The present study found mean gestational age of 38.4±2 weeks, weight of 2871±532.4 g, corresponding to IL-6 of ≤14 pg/uL. in children with a low birth weight of 1015 g and a gestational age of 31 weeks, who are related to prenatal preeclampsia, prenatal UTI, vaginitis/vaginosis, IL6 reaches a value of up to 414 pg/uL, with the P90 percentile up to 215 pg/uL, which is attributed to the presence of early neonatal sepsis.</p>
<p>			Several authors [<xref ref-type="bibr" rid="redalyc_273860963012_ref23">22</xref>,<xref ref-type="bibr" rid="redalyc_273860963012_ref24">23</xref>,<xref ref-type="bibr" rid="redalyc_273860963012_ref25">24</xref>] state that the death rate due to sepsis is high and the risk of sepsis increases in prematurity in proportion to the decrease in birth weight; evaluation of levels of IL-6 and CPR for the diagnosis of early sepsis may explain the difference between septic and non-septic patients. Neonatal sepsis, characterized by systemic signs of infection in the first month of life, remains an important clinical syndrome, with high mortality and morbidity rates; the use of IL-6 and CRP in combination have been shown to be useful in the early diagnosis of sepsis in newborns. It was observed [<xref ref-type="bibr" rid="redalyc_273860963012_ref26">25</xref>, <xref ref-type="bibr" rid="redalyc_273860963012_ref27">26</xref>] that umbilical cord IL-6 above the P75 percentile was associated with an increase in respiratory distress syndrome and chronic lung disease, but not with necrotizing enterocolitis, intraventricular hemorrhage or neonatal sepsis [<xref ref-type="bibr" rid="redalyc_273860963012_ref29">28</xref>]. This association may change after adjustment for weeks of gestation at delivery and the treatment group. In our study, IL-6 P75 percentile, was of 101.5 pg/uL, and is associated with an increase in respiratory distress syndrome. Similarly, other studies demonstrate greater diagnostic accuracy in differentiating sepsis from non-sepsis when measuring IL-6 in combination with CRP.</p>
<p>
<bold>			About the distribution of the relationship between sepsis with prenatal preeclampsia, vaginitis/vaginosis and newborn sex</bold>
</p>
<p>			In the present study, a connection was found between prenatal preeclampsia and neonatal sepsis, as well as between vaginitis and vaginosis with neonatal sepsis. No connection was found between sex of the newborn and sepsis. There was a link discovered between UTI with sepsis, and the values of IL-6 with sepsis, with values lower of 14 pg/uL. Preeclampsia is a risk factor that is attributed to oxidative stress and antioxidant status in neonates born to pre-eclamptic mothers; sepsis due to UTI is due to the invasion and dissemination of bacteria in the urinary system through the described routes, which cause a child of low birth weight and premature newborn. Sepsis secondary to prenatal vaginosis is attributed to vertical transmission. Several authors report that all markers of oxidative stress, including IL-6, were higher in the preeclampsia group compared to controls [<xref ref-type="bibr" rid="redalyc_273860963012_ref28">27</xref>].</p>
<p>
<bold>			The relationship model of the variables with neonatal sepsis</bold>
</p>
<p>			In the present study, binary logistic regression showed an association of sepsis with IL-6 and other risk factors such as gestational age, weight, and prenatal preeclampsia, infections of the urinary tract before birth, vaginitis, and vaginosis. Therefore, it concluded that IL-6 is a predictor of early sepsis associated with prenatal risk factors, previously described.</p>
<p>			Prematurity is attributed as the main risk factor for sepsis, since it is associated with immaturity of the immune system. This is explained by the low levels of immunoglobulin related to the decrease of transplacental transfer of maternal IgG; the decrease in the function of neutrophils and monocytes that manifests itself with the alteration of the function of chemotaxis, opsonization and bacterial phagocytosis; and by a decreased function of the barrier of the skin and mucous membranes. Decreased Sepsis causes high mortality in newborns with low and very low birth weight.</p>
<p>			Several authors [<xref ref-type="bibr" rid="redalyc_273860963012_ref29">28</xref>] did report that the lipopolysaccharide binding protein (LBP), IL-6, and CRP were significantly higher in children with severe sepsis compared with those with less severe sepsis; the mean values of LBP, IL6, and CRP were significantly higher in children with bacteremia compared to those without bacteremia. Therefore, they conclude that elevated levels of LBP, IL-6, and CRP were associated with a more severe level of infection in children. It seems that these biomarkers are good markers to detect patients with bacteremia.</p>
<p>			The IL-6 values of the umbilical cord and funisitis have also been evaluated, as an independent predictor of early-onset neonatal sepsis (EONS), in the presence of premature rupture of membranes. Funisitis was defined according to the classification of Salafia; the data were adjusted for gestational age at the time of delivery and prenatal administration of corticosteroids and antibiotics. IL-6 from the umbilical cord was found to be the only independent predictor of early-onset neonatal sepsis in premature rupture of preterm membranes, which was not observed in funisitis.</p>
<p>			Currently, there is no adequate laboratory test, single or in combination, which has sufficient sensitivity and specificity to allow physicians to safely rule out early-onset sepsis.</p>
<p>			All sick newborns with clinical signs suggestive of sepsis should be treated empirically with antibiotics, once the respective cultures have been taken. Treatment of term infants with a good outcome depends on the number of risk factors that are controlled, including maternal colonization of GBS. Maternal intrapartum antibiotic prophylaxis for GBS must be individualized. Careful evaluation and observation of these newborns with risk factors is a fundamental component of adequate care during the first 24 hours of life.</p>
</sec>
<sec sec-type="conclusions">
<title>
<bold>Conclusion</bold>
</title>
<p> It is concluded that there is a relationship of risk factors, such as gestational age in weeks, weight, prenatal preeclampsia and UTI, vaginitis, vaginosis, and values of interleukin 6 of ≤ 14 pg/uL. The mean gestational age was 38.4 weeks, and average weight 2871 grams in the newborns analyze</p>
<p>
<bold>Contribution of the authors</bold>
</p>
<p>			The research protocol and its design, data collection, statistical analysis, evaluation and interpretation of the data, critical analysis, discussion, writing and approval of the final manuscript were carried out by all authors who contributed in the same way in the whole process. The corresponding author represents the group of authors.</p>
<p>
<bold>			Availability of data and materials</bold>
</p>
<p>			The data supporting this manuscript are available upon request to the corresponding author.</p>
<p>
<bold>			Ethical approval</bold>
</p>
<p>			All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committe and with the 1964 Helsinki Declaration and is later amendments or comparable ethical standars. Informed consent was obtained from all individual participants included in the study.</p>
<p>
<bold>			Consent for publication</bold>
</p>
<p>			The institutions cited in this document gave their consent to use this information.</p>
<p>
<bold>			Informed consent</bold>
</p>
<p>			Informed consent was obtained from all individual participants included in the study.</p>
<p>			Conflict of interest: no financial or nonfinancial benefits have been received or will be received from any party related directly or indirectly to the subject of this paper.</p>
<p>
<bold>			Funding source:</bold> the authors declare that the financial resources for the elaboration of the present investigation do not come from any fund, but from their self-management.</p>
</sec>
</body>
<back>
<ref-list>
<title>
<bold>Cited literature</bold>
</title>
<ref id="redalyc_273860963012_ref1">
<label>1</label>
<mixed-citation>Hornik CP, Fort P, Clark RH, Watt K, Benjamin DK  Jr,  Smith PB, et al. <bold>Early and late onset sepsis in  very-low-birth-weight infants from a large group of neonatal  intensive care units.</bold>
<italic>Early Hum Dev </italic>
2012; 88(Suppl  2):S69-74. DOI: 10.1016/S0378-
3782(12)70019-1</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hornik</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Fort</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>RH</given-names>
</name>
<name>
<surname>Watt</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Benjamin</surname>
<given-names>DK Jr</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>PB</given-names>
</name>
</person-group>
<article-title>Early and late onset sepsis in  very-low-birth-weight infants from a large group of neonatal  intensive care units</article-title>
<source>Early Hum Dev</source>
<year>2012</year>
<volume>88</volume>
<fpage>S69</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="doi">10.1016/S0378-</pub-id>
<supplement>Suppl 2</supplement>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref2">
<label>2</label>
<mixed-citation>Simonsen  KA, Anderson-Berry AL, Delair SF, Davies HD.<bold> Early-onset  neonatal sepsis. </bold>
<italic>Clin Microbiol  Rev </italic>2014;  27(1):21-47. DOI: 10.1128/ CMR.00031-13</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simonsen</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Anderson-Berry</surname>
<given-names>AL</given-names>
</name>
<name>
<surname>Delair</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Davies</surname>
<given-names>HD</given-names>
</name>
</person-group>
<article-title>Early-onset  neonatal sepsis</article-title>
<source>Clin Microbiol Rev</source>
<year>2014</year>
<volume>27</volume>
<issue>1</issue>
<fpage>21</fpage>
<lpage>47</lpage>
<pub-id pub-id-type="doi">10.1128/ CMR.00031-13</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref4">
<label>3</label>
<mixed-citation>Bedford  Russell AR, Kumar R. <bold>Early onset neonatal  sepsis: diagnostic dilemmas and practical management</bold>. <italic>Arch Dis Child Fetal  Neonatal Ed</italic>. 2015; 100(4): F350-4. DOI: 10.1136/archdis- child-2014-306193</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedford Russell</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Early onset neonatal  sepsis: diagnostic dilemmas and practical management</article-title>
<source>Arch Dis Child Fetal Neonatal Ed</source>
<year>2015</year>
<volume>100</volume>
<issue>4</issue>
<fpage>F350</fpage>
<lpage>F354</lpage>
<pub-id pub-id-type="doi">10.1136/archdis- child-2014-306193</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref5">
<label>4</label>
<mixed-citation>Fan Y, Yu JL. <bold>Umbilical  blood biomarkers for predicting  early-onset neonatal sepsis</bold>. <italic>World J Pediatr. </italic>2012; 8(2):101-8. DOI: 10.1007/s12519-
012-0347-3</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>JL</given-names>
</name>
</person-group>
<article-title>Umbilical  blood biomarkers for predicting  early-onset neonatal sepsis</article-title>
<source>World J Pediatr</source>
<year>2012</year>
<volume>8</volume>
<issue>2</issue>
<fpage>101</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1007/s12519- 012-0347-</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref6">
<label>5</label>
<mixed-citation>Chiesa C, Pacifico  L, Natale F, Hofer N, Osborn JF, Resch B.<bold> Fetal and early neonatal interleu- kin-6 response.</bold>
<italic>Cytokine</italic> 2015;  76(1): 1-12. DOI: 
10.1016/j.cyto.2015.03.015</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiesa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pacifico</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Natale</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Osborn</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Fetal and early neonatal interleu- kin-6 response</article-title>
<source>Cytokine</source>
<year>2015</year>
<volume>76</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2015.03.015</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref7">
<label>6</label>
<mixed-citation>Su H, Chang SS, Han CM, Wu KY, Li MC, Huang  CY, et al. <bold>Inflammatory markers in cord blood or maternal serum for early detection  of neonatal sepsis a systemic  review and meta-analysis.</bold>
<italic>J Perinatol </italic>2014; 34(4):268-74. DOI: 10.1038/ jp.2013.186</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>CY</given-names>
</name>
</person-group>
<article-title>Inflammatory markers in cord blood or maternal serum for early detection  of neonatal sepsis a systemic  review and meta-analysis</article-title>
<source>J Perinatol</source>
<year>2014</year>
<volume>34</volume>
<issue>4</issue>
<fpage>268</fpage>
<lpage>274</lpage>
<pub-id pub-id-type="doi">10.1038/ jp.2013.186</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref8">
<label>7</label>
<mixed-citation>Sugitharini V, Prema A, Berla Thangam E. <bold>Inflammatory mediators of systemic inflammation in  neonatal sepsis.</bold>
<italic> Inflamm Res </italic>2013; 62(12):1025-
              34. DOI: 10.1007/s00011-013-0661-9</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugitharini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Prema</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Berla Thangam</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Inflammatory mediators of systemic inflammation in  neonatal sepsis</article-title>
<source>Inflamm Res</source>
<year>2013</year>
<volume>62</volume>
<issue>12</issue>
<fpage>1025</fpage>
<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1007/s00011-013-0661-9</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref9">
<label>8</label>
<mixed-citation>Celik IH, Demirel G, Uras N, Oguz ES, Erdeve O, Dilmen  U.<bold> [The role of serum interleukin-6 and Creactive protein levels for differentiating aetiology  of neonatal sepsis]</bold>. <italic>Arch Argent  Pediatr </italic>2015; 
              113(6):534-7. DOI: 10.5546/aap.2015.534</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Demirel</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Uras</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Oguz</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Erdeve</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Dilmen</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>[The role of serum interleukin-6 and Creactive protein levels for differentiating aetiology  of neonatal sepsis]</article-title>
<source>Arch Argent Pediatr</source>
<year>2015</year>
<volume>113</volume>
<issue>6</issue>
<fpage>534</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="doi">10.5546/aap.2015.534</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref10">
<label>9</label>
<mixed-citation>Khaertynov KS, Boichuk SV, Khaiboullina SF, Anokhin VA, Andreeva  AA, Lombardi VC, et al. <bold>Comparative  Assessment of Cytokine Pattern in Early and Late Onset of Neonatal  Sepsis</bold>. <italic>J Immunol  Res</italic> 2017; 2017:8601063. DOI: 
              10.1155/2017/8601063</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Khaertynov</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Boichuk</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Khaiboullina</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Anokhin</surname>
<given-names>VA</given-names>
</name>
<name>
<surname>Andreeva</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Lombardi</surname>
<given-names>VC</given-names>
</name>
</person-group>
<article-title>Comparative  Assessment of Cytokine Pattern in Early and Late Onset of Neonatal  Sepsis</article-title>
<source>J Immunol Re</source>
<year>2017</year>
<pub-id pub-id-type="doi">10.1155/2017/8601063</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref11">
<label>10</label>
<mixed-citation>Steinberger  E, Hofer N, Resch B. <bold>Cord blood procalcitonin and Interleukin-6 are   highly  sensitive and specific in the prediction  of early-onset sepsis in preterm infants</bold>. <italic>Scand J Clin Lab Invest </italic>2014; 74(5):432-6. DOI: 
              10.3109/00365513.2014.900696</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steinberger</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Cord blood procalcitonin and Interleukin-6 are   highly  sensitive and specific in the prediction  of early-onset sepsis in preterm infants</article-title>
<source>Scand J Clin Lab Invest</source>
<year>2015</year>
<volume>74</volume>
<issue>5</issue>
<fpage>432</fpage>
<lpage>436</lpage>
<pub-id pub-id-type="doi">10.3109/00365513.2014.900696</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref12">
<label>11</label>
<mixed-citation>Celik IH, Demirel FG, Uras N, Oguz SS, Erdeve O, Biyikli Z, Dilmen U. <bold>What are the cut-off  levels for IL-6 and CRP in neonatal  sepsis?</bold>. <italic>J Clin Lab Anal </italic>2010; 24(6):407-12. DOI: 10.1002/jcla.20420</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Celik</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Demirel</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Uras</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Oguz</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Erdeve</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Biyikli</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Dilmen</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>What are the cut-off  levels for IL-6 and CRP in neonatal  sepsis?.</article-title>
<source>J Clin Lab Anal</source>
<year>2010</year>
<volume>24</volume>
<issue>6</issue>
<fpage>407</fpage>
<lpage>412</lpage>
<pub-id pub-id-type="doi">10.1002/jcla.20420</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref13">
<label>12</label>
<mixed-citation>Boskabadi  H, Zakerihamidi M. <bold>Evaluate the diagnosis of neonatal sepsis by measuring interleukins:  A systematic review</bold>.<italic> Pediatr  Neonatol </italic>2018; 59(4):
              329-338. DOI: 10.1016/j.pedneo.2017.10.004</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boskabadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zakerihamidi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Evaluate the diagno- sis of neonatal sepsis by measuring interleukins:  A systematic review</article-title>
<source>Pediatr Neonatol</source>
<year>2018</year>
<volume>59</volume>
<issue>4</issue>
<fpage>329</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/j.pedneo.2017.10.004</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref14">
<label>13</label>
<mixed-citation>Machado JR, Soave DF, da Silva MV, de Menezes LB, Etchebehere RM, Monteiro ML, et al. <bold>Neonatal sepsis and inflammatory mediators.</bold>
<italic>Mediators Inflamm</italic> 2014; 2014:269681. DOI: 10.1155/2014/269681</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machado</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Soave</surname>
<given-names>DF</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>MV</given-names>
</name>
<name>
<surname>de Menezes</surname>
<given-names>LB</given-names>
</name>
<name>
<surname>Etchebehere</surname>
<given-names>RM</given-names>
</name>
<name>
<surname>Monteiro</surname>
<given-names>ML</given-names>
</name>
</person-group>
<article-title>Neonatal sepsis and inflammatory mediators</article-title>
<source>Mediators Inflamm</source>
<year>2014</year>
<volume>2014</volume>
<fpage>269681</fpage>
<pub-id pub-id-type="doi">10.1155/2014/269681</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref15">
<label>14</label>
<mixed-citation>Mirzarahimi M, Barak M, Eslami  A, Enteshari-Moghaddam  A.<bold> The role of interleukin-6 in the early diagnosis of sepsis in premature infants</bold>. <italic>Pediatr Rep</italic> 2017; 9(3):7305. DOI: 10.4081/pr.2017.7305</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Machado</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eslami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Enteshari-Moghaddam</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of interleukin-6 in the early diagnosis of sepsis in premature infants</article-title>
<source>Pediatr Rep</source>
<year>2017</year>
<volume>9</volume>
<issue>3</issue>
<fpage>7305</fpage>
<pub-id pub-id-type="doi">10.4081/pr.2017.7305</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref16">
<label>15</label>
<mixed-citation>Barug D, Goorden  S, Herruer M, Müller M, Brohet  R,  de Winter P. <bold>Reference values for interleukin-6  and interleukin-8 in cord blood of healthy  term neonates and their association with stress-related perinatal factors</bold>. <italic>PLoS One</italic> 2014; 9(12): e114109. DOI: 10.1371/journal.pone.0114109</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barug</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Goorden</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Herruer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Müller</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Brohet</surname>
<given-names>R</given-names>
</name>
<name>
<surname>de Winter</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Reference values for interleukin-6  and interleukin-8 in cord blood of healthy  term neonates and their association with stress-re- lated perinatal factors</article-title>
<source>PLoS One</source>
<year>2014</year>
<volume>9</volume>
<issue>12</issue>
<fpage>e114109</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0114109</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref17">
<label>16</label>
<mixed-citation>Ye Q, Du LZ, Shao WX, Shang SQ. <bold>Utility of cytokines to predict neonatal  sepsis</bold>. <italic>Pediatr Res</italic> 2017; 81(4):616-621. DOI: 10.1038/pr.2016.267.E</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ye</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>LZ</given-names>
</name>
<name>
<surname>Shao</surname>
<given-names>WX</given-names>
</name>
<name>
<surname>Shang</surname>
<given-names>SQ</given-names>
</name>
</person-group>
<article-title>Utility of cytokines to predict neonatal  sepsis</article-title>
<source>Pediatr Res</source>
<year>2017</year>
<volume>81</volume>
<issue>4</issue>
<fpage>616</fpage>
<lpage>621</lpage>
<pub-id pub-id-type="doi">10.1038/pr.2016.267.E</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref18">
<label>17</label>
<mixed-citation>Chauhan N, Tiwari S, Jain U.<bold> Potential biomarkers for effective  screening of neonatal sepsis infections:  An overview.</bold>
<italic>Microb Pathog </italic>2017; 107:234-242.  DOI: 10.1016/j.micpath.2017.03.042</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chauhan</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Tiwari</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Jain</surname>
<given-names>U</given-names>
</name>
</person-group>
<article-title>Potential biomark- ers for effective  screening of neonatal sepsis infections:  An overview</article-title>
<source>Microb Pathog</source>
<year>2017</year>
<volume>107</volume>
<fpage>234</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="doi">10.1016/j.micpath.2017.03.042</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref19">
<label>18</label>
<mixed-citation>Mirzarahimi M, Barak M, Eslami  A, Enteshari-Moghaddam  A.<bold> The role of interleukin-6 in the early diagnosis of sepsis in premature infants.</bold> Pediatr Rep 2017; 9(3): 7305. DOI: 10.4081/pr.2017.7305</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirzarahimi</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Barak</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Eslami</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Enteshari-Moghaddam</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The role of interleukin-6 in the early diagnosis of sepsis in premature infants</article-title>
<source>Pediatr Rep</source>
<year>2017</year>
<volume>9</volume>
<issue>3</issue>
<fpage>7305</fpage>
<lpage>7305</lpage>
<pub-id pub-id-type="doi">10.4081/pr.2017.7305</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref20">
<label>19</label>
<mixed-citation>Chiesa C, Pacifico  L, Natale F, Hofer N, Osborn JF, Resch B.<bold> Fetal and early neonatal  interleu- kin-6 response</bold>. Cytokine. 2015; 76(1):1-12. DOI: 10.1016/j.cyto.2015.03.015</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiesa</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Pacifico</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Natale</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Hofer</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Osborn</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Resch</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Fetal and early neonatal  interleu- kin-6 response</article-title>
<source>Cytokine</source>
<year>2015</year>
<volume>76</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1016/j.cyto.2015.03.015</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref21">
<label>20</label>
<mixed-citation>Boskabadi H, Zakerihamidi M. <bold>Evaluate the diagnosis  of neonatal sepsis by measuring interleukins: A  systematic review.</bold>
<italic>Pediatr Neonatol</italic> 2018; 59(4): 329-338. DOI: 10.1016/j.pedneo.2017.10.004</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boskabadi</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Zakerihamidi</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Evaluate the diagnosis  of neonatal sepsis by measuring interleukins: A  systematic review</article-title>
<source>Pediatr Neonatol</source>
<year>2018</year>
<volume>59</volume>
<issue>4</issue>
<fpage>329</fpage>
<lpage>338</lpage>
<pub-id pub-id-type="doi">10.1016/j.pedneo.2017.10.004</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref22">
<label>21</label>
<mixed-citation>Sorokin Y, Romero R, Mele L, Iams JD, Peaceman AM, Leveno KJ, et al.<bold> Umbilical cord serum  interleukin-6, Creactive protein,  and myeloperoxidase concentrations at birth and association with neonatal morbidities and long-term neurodevelopmental outcomes</bold>. <italic>Am J Perinatol </italic>2014; 31(8):717-26. DOI: 10.1055/s-0033-1359723</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sorokin</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Romero</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Mele</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Iams</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Peace-man</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Leveno</surname>
<given-names>KJ</given-names>
</name>
</person-group>
<article-title>Umbilical cord serum  interleukin-6, C-reactive protein,  and myeloperoxidase concentrations at birth and association with neonatal morbidities and long-term neurodevelopmental outcomes</article-title>
<source>Am J Perinatol</source>
<year>2014</year>
<volume>31</volume>
<issue>8</issue>
<fpage>717</fpage>
<lpage>726</lpage>
<pub-id pub-id-type="doi">10.1055/s-0033-1359723</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref23">
<label>22</label>
<mixed-citation>Alves JB, Gabani FL, Ferrari  RAP, Tacla MTGM, Linck Júnior A. <bold>Neonatal sepsis: mortality in a municipality in southern Brazil, 2000 to 2013</bold>. <italic>Rev Paul Pediatr</italic> 2018; 36(2): 132-140.  DOI:  10.1590/1984-0462</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alves</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Gabani</surname>
<given-names>FL</given-names>
</name>
<name>
<surname>Ferrari</surname>
<given-names>RAP</given-names>
</name>
<name>
<surname>Tacla</surname>
<given-names>MTGM</given-names>
</name>
<name>
<given-names>Linck</given-names>
</name>
<name>
<surname>Linck Júnior</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title> Neonatal sepsis: mortality in a municipality in southern Brazil, 2000 to 2013. </article-title>
<source>Am J Perinatol</source>
<year>2013</year>
<volume>36</volume>
<issue>2</issue>
<fpage>132</fpage>
<lpage>140</lpage>
<pub-id pub-id-type="doi">10.1590/1984-0462</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref24">
<label>23</label>
<mixed-citation>Molloy EJ, O’Neill  SM. <bold>Neonatal Escherichia  coli sepsis: possible effects of gender, type of surfactant, or time to initiation of antibiotics?</bold>. <italic>Am J Obstet Gynecol</italic> 2006; 194(4):1201-2. DOI: 10.1016/j.ajog.2005.07.088</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molloy</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>O’Neill</surname>
<given-names>SM</given-names>
</name>
</person-group>
<article-title>Neonatal Escherichia  coli sepsis: possible effects of gender, type of surfactant, or time to initiation of antibiotics?</article-title>
<source>Am J Obstet Gynecol</source>
<year>2006</year>
<volume>194</volume>
<issue>4</issue>
<fpage>1201</fpage>
<lpage>1202</lpage>
<pub-id pub-id-type="doi">10.1016/j.ajog.2005.07.088</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref25">
<label>24</label>
<mixed-citation>Kurt AN, Aygun AD, Godekmerdan A, Kurt A, Dogan  Y, Yilmaz E. <bold>Serum IL-1beta,IL-6, IL-8, and TNF-al-  ha levels in early diagnosis  and management of neonatal  sepsis</bold>.<italic> Mediators Inflamm </italic>2007; 2007: 31397. DOI: 10.1155/2007/31397</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kurt</surname>
<given-names>AN</given-names>
</name>
<name>
<surname>Aygun</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Godekmerdan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kurt</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dogan</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Yilmaz</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Serum IL-1beta,IL-6, IL-8, and TNF-al-  ha levels in early diagnosis  and management of neonatal  sepsis</article-title>
<source>Mediators Inflamm</source>
<year>2007</year>
<volume>2007</volume>
<issue>31397</issue>
<pub-id pub-id-type="doi">10.1155/2007/3139</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref26">
<label>25</label>
<mixed-citation>Bhandari V. <bold>Effective  Biomarkers for Diagnosis of Neonatal Sepsis.</bold>
<italic> J Pediatric Infect Dis Soc </italic>2014; 3(3):234-45. DOI: 10.1093/jpids/piu063</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhandari</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Effective  Biomarkers for Diagnosis of Neonatal Sepsi</article-title>
<source>J Pediatric Infect Dis Soc</source>
<year>2014</year>
<volume>3</volume>
<issue>3</issue>
<fpage>234</fpage>
<lpage>245</lpage>
<pub-id pub-id-type="doi">10.1093/jpids/piu063</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref27">
<label>26</label>
<mixed-citation>Sugitharini V, Prema A, Berla Thangam E<bold>. Inflammatory mediators of systemic  inflammation in neonatal sepsis</bold>. <italic>Inflamm Res</italic> 2013; 62(12):1025-34. DOI: 10.1007/s00011-013-0661-9</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sugitharini</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Prema</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Thangam</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Inflammatory mediators of systemic  inflammation in neonatal sepsis</article-title>
<source>Inflamm Res</source>
<year>2013</year>
<volume>62</volume>
<issue>12</issue>
<fpage>1025</fpage>
<lpage>1034</lpage>
<pub-id pub-id-type="doi">10.1007/s00011-013-0661-9</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref28">
<label>27</label>
<mixed-citation>Krauss-Silva L, Moreira  ME, Alves MB, Rezende  MR, Braga A, Camacho KG, et al. <bold>Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol.</bold>
<italic>Reprod Health </italic>2010; 7:14. DOI: 10.1186/1742-4755-7-14</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krauss-Silva</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Moreira</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Alves</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Rezende</surname>
<given-names>MR</given-names>
</name>
<name>
<surname>Braga</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Camacho</surname>
<given-names>KG</given-names>
</name>
</person-group>
<article-title>Randomized controlled trial of probiotics for the prevention of spontaneous preterm delivery associated with intrauterine infection: study protocol</article-title>
<source>Reprod Health</source>
<year>2010</year>
<fpage>7</fpage>
<lpage>14</lpage>
<pub-id pub-id-type="doi">10.1186/1742-4755-7-14</pub-id>
</element-citation>
</ref>
<ref id="redalyc_273860963012_ref29">
<label>28</label>
<mixed-citation>Pavare J, Grope  I, Kalnins I, Gardovska D. <bold>High- mobility group box-1 protein, lipopolysaccharide-binding protein,  interleukin-6 and C-reactive protein in children with community  acquired infections and bacteraemia: a prospective study. </bold>
<italic>BMC Infect Dis </italic>2010; 10:28. DOI: 10.1186/1471- 2334-10-28</mixed-citation>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pavare</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grope</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Kalnins</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Gardovska</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>High- mobility group box-1 protein, lipopolysaccharide-binding protein,  interleukin-6 and Creactive protein in children with community  acquired infections and bacteraemia: a prospective study</article-title>
<source>BMC Infect Dis</source>
<year>2010</year>
<fpage>10</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1186/1471- 2334-10-28</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>